Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health topic
No spam. Unsubscribe anytime.
Committee approves bill requiring RSV notifications in child-care settings and annual sickle-cell treatment review
Summary
Senate panel approved House Bill 334 to require child-care providers and family child centers to notify parents when a child has RSV and asked the Department of Community Health to conduct annual reviews of sickle-cell treatments. Sponsors said the measures will protect infants and those living with sickle-cell disease.
Senators unanimously approved House Bill 334 on Wednesday, a bill that would require child-care and family child centers to notify parents when a child in care has respiratory syncytial virus (RSV) and direct the Department of Community Health to conduct an annual review of medications and treatments for people with sickle-cell disease.
Sponsor Rosetta Crawford said the RSV provision would give parents notice if a child at their child-care center has RSV so they can take precautions. She also said the Department of Community Health supports an annual review of sickle-cell treatments to ensure clinical guidance keeps pace with new medications and therapies. The sponsor noted about 15,000 Georgians live with sickle-cell disease and that every county has people affected.
The committee passed the bill unanimously by voice vote.
Ending: The bill moves forward after unanimous committee approval.
